Islet Holding Inc (ISHI) 0.0216 $ISHI
Islet Holdings, Inc. Announces Worldwide Exclusive Agreements Signed With Apollon Formularies, Inc. and Last Call Ventures, Inc. to Assist in Producing a Full Line of Flavored CBD and Hemp Oil Based Nutraceutical Products
GlobeNewswire - Wed Apr 15, 7:11AM CDT
Islet Holdings, Inc. (OTC:ISHI) ("the Company"

recently announced they would expand their business plan to pursue new medical technologies and products based around development, production, and sales of cannabidiol (CBD) oil. CBD is one of approximately 85 cannabinoids present in the Cannabis plant. A British study recently suggested that cultivation of Cannabis plants rich in Cannabidiol (CBD) and other phenolic substances would be useful for medicinal purposes in the treatment of certain inflammatory disorders. In this study, "CBD was found to be more effective than aspirin as an anti-inflammatory agent."
Islet Holdings, Inc. Continues With Pursuing Damages in Federal Court
GlobeNewswire - Thu Mar 26, 7:11AM CDT
Islet Holdings, Inc. (OTC:ISHI) ("the Company"

previously announced that in August 2012, the Company and its subsidiary filed a complaint in Federal District Court for the District of Utah against Islet Sciences, Inc., a publicly-held company trading under the symbol "ISLT", and several individuals intimately involved with Islet Sciences. The complaint is related to the Company's prior work and development in the type 1 diabetes treatment industry.
Islet Holdings, Inc. Adds New Business Pursuits
BusinessWire - Wed Dec 03, 12:29PM CST
Islet Holdings, Inc. (Pink Sheets:ISHI)("the Company"

recently announced that the Company would expand its business plan to pursue additional and new medical technologies and products. Today the Company announced that it has added the development, production, and sales of cannabidiol (CBD) oil to its business plan. CBD is one of approximately 85 cannabinoids present in the Cannabis plant.